In this section we provide information about new medications that have been approved for use in multiple sclerosis. For each medication, two information sheets are available – one for people with MS and one for clinicians. The information in these resources, developed from peer-reviewed publications and U.S. Food and Drug Administration (FDA) prescribing information, has been reviewed and approved by each of the organizations participating in this collaborative. The purpose of the information sheets is to facilitate effective conversations and collaborative decision-making between people with MS and their healthcare professionals about the possible benefits and risks of each of these treatments.
Disease Modifying Therapies